Evidence map›Paper›PMID 36435761›Full record

ArticleBMC infectious diseases2022

Prevalence and correlates of substance use and associations with HIV-related outcomes among trans women in the San Francisco Bay Area.

Elaine Hsiang, Akua Gyamerah, Glenda Baguso, Jennifer Jain, Willi McFarland, Erin C Wilson, Glenn-Milo Santos

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Elaine HsiangDepartment of Emergency Medicine, University of California, San Francisco, 505 Parnassus Avenue, M24, Box 203, San Francisco, CA, 94143, USA. elaine.hsiang@ucsf.edu.ORCID http://orcid.org/0000-0002-1393-8204
Akua GyamerahDepartment of Community Health Systems, University of California, San Francisco, San Francisco, CA, USA.
Glenda BagusoCenter for Public Health Research, San Francisco Department of Public Health, University of California, San Francisco, San Francisco, CA, USA.
Jennifer JainDepartment of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.
Willi McFarlandCenter for Public Health Research, San Francisco Department of Public Health, University of California, San Francisco, San Francisco, CA, USA.
Erin C WilsonCenter for Public Health Research, San Francisco Department of Public Health, University of California, San Francisco, San Francisco, CA, USA.
Glenn-Milo SantosDepartment of Community Health Systems, University of California, San Francisco, San Francisco, CA, USA.
University of California, San Francisco · US

Funding

TRAINEESHIPS IN AIDS PREVENTION STUDIEST32MH019105 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carol Suzanne Camlin, Glenn-Milo Santos · 1989 to 2026
$15.3M
Substance Use and HIV Prevention Research in Minority Communities Training ProgramR25DA028567 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Julia Lechuga, Torsten Brian Neilands · 2009 to 2026
$5.4M
The Transnational Cohort: global HIV epidemiology and prevention research for transwomen.R01MD010678 · NIMHD · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI MCFARLAND, WILLIAM, MEEK, ERIN CATHERINE · 2015 to 2019
$2.4M
Women, Intersectionality, Substance Use and HIV ( WISH)K01DA056306 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Payaal Jain · 2022 to 2026
$1.0M
NIDA NIH HHS K01 DA056306NIDA NIH HHS L60 DA054664NIDA NIH HHS R25 DA028567NIMHD NIH HHS R01 MD010678NIMH NIH HHS R01MD010678NIMH NIH HHS T32 MH019105
6 · The paper itself

Abstract

backgroundTrans women face tremendous social inequities as well as disproportionate rates of HIV and substance use, yet disaggregated substance use data specific to trans women remain limited.

methodsWe conducted a secondary analysis of baseline data from the Trans*National Study (2016-2017) surveying trans women in the San Francisco Bay Area (n = 629). Multivariable logistic regression was used to analyze socio-demographic and environmental correlates of substance use, and bivariate associations between substance use and HIV-associated outcomes are presented alongside prevalence data.

resultsOver half (52.9%) reported using substances in the prior year, most frequently marijuana, methamphetamine, and crack/cocaine. Those with unmet gender-affirming health care needs, lack of insurance, or a history of experiencing racial violence, transphobic violence, adult housing instability, or extreme poverty had higher odds of substance use. Sex work and condomless anal sex were also independently associated with substance use.

conclusionsAmong this sample of trans women, substance use and substance use concurrent with sex were highly prevalent, and associated with a number of socioeconomic and health care needs. These findings corroborate the need for holistic and intersectional efforts to reduce substance use and HIV risk.

Indexed as

HIV InfectionsSubstance-Related DisordersAdultFemaleHumansPrevalenceSan FranciscoUnsafe SexDiscriminationHIVSocial determinants of healthSubstance useTransgender persons

Identifiers

PMID36435761
PMCPMC9701418
OpenAlexW4310272920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.